Document is current
Any future updates will be listed below
-
Authors
Khan, Sarah https://orcid.org/0000-0003-3604-303X
Khan, Aliya A.
- License Information
-
More Information
Article History
Accepted: 29 November 2024
First Online: 4 February 2025
Competing interests
: A.K. is primary investigator for trials funded by Ascendis, Amolyt, Calcilytix and Alexion. S.K. has received honoraria and served on advisory boards for Amgen Pharmaceuticals and Sandoz Pharmaceuticals. She is a co-investigator for trials funded by Calcilytix and Ascendis. She is a primary investigator for a trial funded by Ultragenyx.
